LIVN

LivaNova PLC Ordinary Shares

89.99

USD

-1.15

-1.26%

Nov 06, 15:59 UTC -5

Closed

After-Market

89.98

0.00

-0.01%

LivaNova PLC Ordinary Shares (LIVN) Earnings

LIVN Earnings Reports

Positive Surprise Ratio

LIVN beat 36 of 43 last estimates.

84%

Next Report

Date of Next Report

Feb 23, 2027

Estimate for Q4 26 (Revenue/ EPS)

$398.06M

$1.07

Implied change from Q3 26 (Revenue/ EPS)

+1.26%

-13.01%

Implied change from Q4 25 (Revenue/ EPS)

+10.30%

+24.42%

LivaNova PLC Ordinary Shares earnings per share and revenue

On Nov 04, 2026, LIVN reported earnings of 1.23 USD per share (EPS) for Q3 26, beating the estimate of 1.07 USD, resulting in a 14.06% surprise. Revenue reached 393.10 million, compared to an expected 388.69 million, with a 1.14% difference. The market reacted with a +17.88% price change (close before vs. close after earnings).

Looking ahead to Q4 26, 9 analysts forecast an EPS of 1.07 USD, with revenue projected to reach 398.06 million USD, implying an decrease of -13.01% EPS, and increase of 1.26% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

TransMedics Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.29

Actual

$0.51

Surprise

+71.31%

GLOBUS MEDICAL INC

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.22

Actual

$1.23

Surprise

+0.75%

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Treace Medical Concepts, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.67%

Inogen Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.56

Surprise

-285.41%

Envoy Medical, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.68

Actual

-$0.50

Surprise

+26.47%

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

FAQ

What were LivaNova PLC Ordinary Shares's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, LivaNova PLC Ordinary Shares reported EPS of $1.23, beating estimates by 14.06%, and revenue of $393.10M, 1.14% above expectations.

How did the market react to LivaNova PLC Ordinary Shares's Q3 2026 earnings?

The stock price moved up 17.88%, changed from $79.90 before the earnings release to $94.19 the day after.

When is LivaNova PLC Ordinary Shares expected to report next?

The next earning report is scheduled for Feb 23, 2027.

What are the forecasts for LivaNova PLC Ordinary Shares's next earnings report?

Based on 9 analysts, LivaNova PLC Ordinary Shares is expected to report EPS of $1.07 and revenue of $398.06M for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.